Hepatitis B virus X protein and c-Myc cooperate in the upregulation of ribosome biogenesis and in cellular transformation

FEBS Journal

Volumn 279, Issue 20, 2012, Pages 3859-3871

  Shukla, Surendra Kumar ^a   Kumar, Vijay ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

c Myc; HBx; ribosome biogenesis; RNA polymerase I; rRNA

Indexed keywords

CISPLATIN; DNA DIRECTED RNA POLYMERASE III; HEPATITIS B VIRUS X PROTEIN; MYC PROTEIN; RIBOSOME RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; MOUSE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RIBOSOME; RIBOSOME BIOGENESIS; RNA SYNTHESIS; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMES; RNA INTERFERENCE; RNA, RIBOSOMAL; TRANS-ACTIVATORS; UP-REGULATION;

HEPATITIS B VIRUS;

EID: 84867098526     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08745.x     Document Type: Article

References (59)

1. Montanaro L, Trere D, &, Derenzeni M, (2012) Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim Biophys Acta 1825, 101-110.
2. Topisirovic I, &, Sonenberg N, (2011) Translational control by the eukaryotic ribosome. Cell 145, 333-334.
3. White RJ, (2008) RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet 24, 622-629.
4. Cisterna B, &, Biggiogera M, (2010) Ribosome biogenesis: from structure to dynamics. Int Rev Cell Mol Biol 284, 67-111.
5. Kressler D, Hurt E, &, Bassler J, (2010) Driving ribosome assembly. Biochim Biophys Acta 1803, 673-683.
6. Ruggero D, &, Pandolfi PP, (2003) Does the ribosome translate cancer? Nat Rev Cancer 3, 179-192.
7. Wang HD, Trivedi A, &, Johnson DL, (1998) Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol 18, 7086-7094.
8. Tang H, Oishi N, Kaneko S, &, Murakami S, (2006) Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci 97, 977-983.
9. Wang HD, Yuh CH, Dang CV, &, Johnson DL, (1997) The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes. Mol Cell Biol 15, 6720-6728.
10. Benhenda S, Cougot D, Buendia M, &, Neuveut C, (2009) Hepatitis B virus X protein: molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 103, 75-109.
11. Oskarsson T, &, Trumpp A, (2005) The Myc trilogy: lord of RNA polymerases. Nat Cell Biol 7, 215-217.
12. Fatima G, Mathan G, &, Kumar V, (2012) The HBx protein of hepatitis B virus regulates the expression, intracellular distribution and functions of ribosomal protein S27a. J Gen Virol 93, 706-715.
13. Kim YC, Song KS, Yoon G, Nam MJ, &, Ryu WS, (2001) Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. Oncogene 20, 16-23.
14. Terradillos O, Billet O, Renard CA, Levy R, Molina T, &, Briand MA, (1999) The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14, 395-404.
15. Feitelson MA, (2004) c-Myc overexpression in hepatocarcinogenesis. Hum Pathol 35, 1299-1302.
16. Patel JH, Loboda AP, Showe MK, Showe LC, &, McMahon SB, (2004) Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 4, 562-568.
17. Dang CV, (2010) Enigmatic MYC conducts an unfolding systems biology symphony. Genes Cancer 1, 526-531.
18. Poortinga G, Hannan KM, Snelling H, Walkley CR, Jenkins A, Sharkey K, Wall M, Brandenburger Y, Palatsides M, Pearson RB, et al,. (2004) MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation. EMBO J 23, 3325-3335.
19. Poortinga G, Wall M, Sanij E, Siwicki K, Ellul J, Brown D, Holloway TP, Hannan RD, &, McArthur GA, (2011) c-MYC co-ordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation. Nucleic Acids Res 39, 3267-3281.
20. Gomez-Roman N, Grandori C, Eisenman RN, &, White RJ, (2003) Direct activation of RNA polymerase III transcription by c-Myc. Nature 421, 290-294.
21. Grandori A, Gomez N, Felton Z, Ngounet C, Galloway D, Eisenman R, &, White RJ, (2005) c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7, 311-318.
22. Schippers JI, Moshage H, Roelofsen H, Muller M, Heymans HSA, Ruiters M, &, Kuipers F, (1997) Immortalized human hepatocytes as a tool for the study of hepatocytic (de-) differentiation. Cell Biol Toxicol 13, 375-386.
23. Lakhtakia R, Kumar V, Reddi H, Mathur M, Dattagupta S, &, Panda SK, (2003) Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: a sequential pathological evaluation. J Gastroenterol Hepatol 18, 80-91.
24. Boisvert FM, van Koningsbruggen S, Navascues J, &, Lamond AI, (2007) The multifunctional nucleolus. Nat Rev Mol Cell Biol 8, 574-585.
25. Derenzini M, Trerè D, Pession A, Govoni M, Sirri P, &, Chieco P, (2000) Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol 191, 181-186.
26. Mondal NK, Ghosh S, &, Ray MR, (2010) Quantitative analysis of AgNOR proteins in buccal epithelial cells of Indian street boys addicted to gasp 'golden glue'. Exp Toxicol Pathol 63, 677-681.
27. Williams GH, &, Stoeber K, (2012) The cell cycle and cancer. J Pathol 226, 352-364.
28. Koromilas AE, Lazaris-Karatzas A, &, Sonenberg N, (1992) mRNAs containing extensive secondary structure in their 5' non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J 11, 4153-4158.
29. Jordan P, &, Carmo-Fonseca M, (1998) Cisplatin inhibits synthesis of ribosomal RNA in vivo. Nucleic Acids Res 26, 2831-2896.
30. Steinberg TH, Mathews DE, Durbin RD, &, Burgess R, (1990) Tagetoxin: a new inhibitor of eukaryotic transcription by RNA polymerase III. J Biol Chem 265, 499-505.
31. Freed EF, Bleichert F, Dutca LM, &, Baserga SJ, (2010) When ribosomes go bad: diseases of ribosome biogenesis. Mol BioSyst 6, 481-493.
32. Amsterdam A, Sadler KC, Lai K, Farrington S, Bronson RT, Lees JA, &, Hopkins N, (2004) Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2, e139.
33. Williamson D, Lu YJ, Fang C, Pritchard-Jones K, &, Shipley J, (2006) Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma. Genes Chromosom Cancer 45, 839-845.
34. van Riggelen J, Yetil A, &, Felsher DW, (2010) MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 10, 301-308.
35. Moore PB, &, Steitz TA, (2002) The involvement of RNA in ribosome function. Nature 418, 229-235.
36. Belin S, Beghin A, Solano-González E, Bezin L, Brunet-Manquat S, Textoris J, Prats AC, Mertani HC, Dumontet C, &, Diaz JJ, (2009) Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS ONE 4, e7147.
37. Chédin S, Laferté A, Hoang T, Lafontaine DL, Riva M, &, Carles C, (2007) Is ribosome synthesis controlled by pol I transcription? Cell Cycle 6, 11-15.
38. Huang R, Wu T, Xu L, Liu A, Ji Y, &, Hu G, (2002) Upstream binding factor up-regulated in hepatocellular carcinoma is related to the survival and cisplatin-sensitivity of cancer cells. FASEB J 16, 293-301.
39. Grisendi S, Mecucci C, Falini B, &, Pandolfi PP, (2006) Nucleophosmin and cancer. Nat Rev Cancer 6, 493-505.
40. Koh CM, Gurel B, Sutcliffe S, Aryee MJ, Schultz D, Iwata T, Uemura M, Zeller KI, Anele U, Zheng Q, et al,. (2011) Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene. Am J Pathol 178, 1824-1834.
41. Storck S, Shukla M, Dimitrov S, &, Bouvet P, (2007) Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 41, 125-144.
42. Bryan AK, Goranov A, Amon A, &, Manalis SA, (2010) Measurement of mass, density, and volume during the cell cycle of yeast. Proc Natl Acad Sci USA 107, 999-1004.
43. Iritani BM, &, Eisenman RN, (1999) c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci USA 96, 13180-13185.
44. Rhoads RE, (1991) Protein synthesis, cell growth and oncogenesis. Curr Opin Cell Biol 3, 1019-1024.
45. Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, &, Sonenberg N, (2004) eIF4E-from translation to transformation. Oncogene 23, 3172-3179.
46. Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, &, Robertson ES, (2011) Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1. PLoS Pathog 7, e1001275.
47. Pardee AB, (1989) G1 events and regulation of cell proliferation. Science 246, 603-608.
48. Fumagalli S, Ivanenkov VV, Teng T, &, Thomas G, (2012) Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev 26, 1028-1040.
49. Bieging KT, &, Attardi LD, (2012) Deconstructing p53 transcriptional networks in tumor suppression. Trends Cell Biol 22, 97-106.
50. Chan JC, Hannan KM, Riddell K, Ng PY, &, Peck A, (2011) AKT promotes rRNA synthesis and cooperate with c-Myc to stimulate ribosome biogenesis in cancer. Sci Signal 4, ra56.
51. Chung TW, Lee YC, &, Kim CH, (2004) Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERKs and PI3K/AKT pathways: involvement of invasive potential. FASEB J 18, 1123-1125.
52. Lee YI, Kang-Park S, Do S, &, Lee YI, (2001) The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signalling cascade. J Biol Chem 20, 16969-16977.
53. Stefanovsky V, &, Moss T, (2008) The splice variants of UBF differentially regulate RNA polymerase I transcription elongation in response to ERK phosphorylation. Nucleic Acids Res 36, 5093-5101.
54. Mukherji A, Janbandhu VC, &, Kumar V, (2007) HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1. Biochem J 401, 247-256.
55. Hung L, &, Kumar V, (2004) Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs. FEBS Lett 560, 210-214.
56. Khattar E, &, Kumar V, (2010) Mitogenic regulation of p27 (Kip1) gene is mediated by AP-1 transcription factors. J Biol Chem 285, 4554-4561.
57. Schmittgen TD, &, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3, 1101-1118.
58. Goodfellow SJ, Innes F, Derblay LE, MacLellan WR, Scott PH, &, White RJ, (2006) Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J 25, 1522-1533.
59. Belin S, Hacot S, Daudignon L, Therizols G, Pourpe S, Mertani HC, Rosa-Calatrava M, &, Diaz JJ, (2010) Purification of ribosomes from human cell lines. Curr Protoc Cell Biol 49, 3.40.1-3.40.11.